These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34309117)

  • 1. Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.
    Ni W; Yu S; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D; Zhao J; Gao Y
    Oncologist; 2021 Dec; 26(12):e2151-e2160. PubMed ID: 34309117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma.
    Li J; Qiu R; Hu Y; Wang Y; Qi Z; He M; Li Y
    Biomed Res Int; 2021; 2021():8571438. PubMed ID: 33553432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes.
    Zou B; Pang J; Liu Y; Xu Y; Li L; Zhou L; Zhu J; Huang M; Wang J; Ren L; Gong Y; Lu Y; Chen L; Peng F
    Thorac Cancer; 2016 Sep; 7(5):515-521. PubMed ID: 27766781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma.
    Song T; Chen P; Fang M; Zhang X; Du D; Wu S
    Cancer Manag Res; 2020; 12():1631-1639. PubMed ID: 32184666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
    Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
    Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
    Deng W; Yang J; Ni W; Li C; Chang X; Han W; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Deng L; Wang W; Bi N; Zhang T; Li Y; Gao S; Xue Q; Mao Y; Sun K; Liu X; Fang D; Wang D; Li J; Zhao J; Shao K; Li Z; Chen X; Han L; Wang L; He J; Xiao Z
    Oncologist; 2020 Apr; 25(4):e701-e708. PubMed ID: 32083766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retromolar trigone squamous cell carcinoma: A population-based analysis of survival.
    Comer JC; King RB; Harris AB; Hitchcock KE; Mendenhall WM; Bates JE; Dziegielewski PT
    Oral Oncol; 2022 Apr; 127():105767. PubMed ID: 35217400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
    Shen WY; Ji J; Zuo YS; Pu J; Xu YM; Zong CD; Tao GZ; Chen XF; Ji FZ; Zhou XL; Han JH; Wang CS; Yi JG; Su XL; Zhu WG
    Radiother Oncol; 2014 Jan; 110(1):120-5. PubMed ID: 24183868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.
    Xu Y; Liu J; Du X; Sun X; Zheng Y; Chen J; Li B; Liu W; Jiang H; Mao W
    Radiat Oncol; 2013 May; 8():116. PubMed ID: 23656920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Concurrent Chemoradiotherapy versus Postoperative Radiotherapy Alone for Larynx Squamous Cell Carcinoma Patients with Lymphovascular Invasion: A Propensity Score Matching Study.
    Yu S; Zhu Y; Shi X; Hu K; Bai C; Diao W; Zhu X; Gao Z; Chen X
    Cancer Manag Res; 2020; 12():4063-4071. PubMed ID: 32581580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis.
    Li D; Li W; Pang Y; Xu L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(28):e29580. PubMed ID: 35839033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study.
    Ni W; Chen J; Xiao Z; Yu S; Zhang W; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D
    Thorac Cancer; 2019 Jun; 10(6):1431-1440. PubMed ID: 31102336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A
    Ni W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J
    Front Oncol; 2022; 12():936684. PubMed ID: 36158699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma.
    Lin HN; Chen LQ; Shang QX; Yuan Y; Yang YS
    Int J Surg; 2020 Aug; 80():184-191. PubMed ID: 32659390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
    Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
    Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
    Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis.
    Liu D; Wu S; Ni J; Xiang J; Zhang J
    Cancer Control; 2024; 31():10732748241285142. PubMed ID: 39259654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.